Literature DB >> 17645593

Cholestatic liver disease in adults may be due to an inherited defect in bile acid biosynthesis.

B Fischler1, K Bodin, H Stjernman, M Olin, M Hansson, J Sjövall, I Björkhem.   

Abstract

BACKGROUND: An increasing number of treatable inborn errors of bile acid synthesis have been described, primarily in infants with severe cholestatic liver disease.
RESULTS: The present patient, whose two older siblings had died from progressive cholestatic liver disease, developed neonatal cholestasis and rickets but recovered during the childhood years and follow-up was terminated at 12 years of age. The patient presented again at 26 years of age with jaundice and pathological liver function tests. This was normalized upon treatment with ursodeoxycholic acid. Electrospray mass spectrometry of urine showed predominance of unsaturated bile acids, characteristic of 3beta-hydroxy-Delta5-C27-steroid dehydrogenase/isomerase (HSD3B7) deficiency. The activity of HSD3B7 in cultured fibroblasts was less than 5% of normal. A single homozygous mutation was found in exon 4 leading to an amino acid exchange (S162R) and loss of enzyme activity.
CONCLUSION: This case illustrates that infants with an inherited absence of HSD3B7 may survive the neonatal period of life and childhood without treatment with bile acids. A low level of sulphation of the abnormal trihydroxy bile acid formed as a result of enzyme deficiency may be of importance for survival. The possibility that liver disease presenting in the adult may be due to a mutation in the HSD3B7 gene should be considered, especially in cases with familial occurrence of liver disease and earlier periods of liver dysfunction.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17645593     DOI: 10.1111/j.1365-2796.2007.01814.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  7 in total

Review 1.  Disorders of bile acid synthesis.

Authors:  Peter Theodore Clayton
Journal:  J Inherit Metab Dis       Date:  2011-01-13       Impact factor: 4.982

2.  Homozygosity mapping identifies a bile acid biosynthetic defect in an adult with cirrhosis of unknown etiology.

Authors:  Vered Molho-Pessach; Jonathan J Rios; Chao Xing; Kenneth D R Setchell; Jonathan C Cohen; Helen H Hobbs
Journal:  Hepatology       Date:  2012-02-08       Impact factor: 17.425

Review 3.  Bile acids: chemistry, physiology, and pathophysiology.

Authors:  Maria J Monte; Jose J G Marin; Alvaro Antelo; Jose Vazquez-Tato
Journal:  World J Gastroenterol       Date:  2009-02-21       Impact factor: 5.742

Review 4.  Bile acids: analysis in biological fluids and tissues.

Authors:  William J Griffiths; Jan Sjövall
Journal:  J Lipid Res       Date:  2010-01       Impact factor: 5.922

5.  Prognosis and clinical characteristics of patients with 3β-hydroxy-Δ5-C27-steroid dehydrogenase deficiency diagnosed in childhood: A systematic review of the literature.

Authors:  Yuan Zhang; Chun-Feng Yang; Wen-Zhen Wang; Yong-Kang Cheng; Chu-Qiao Sheng; Yu-Mei Li
Journal:  Medicine (Baltimore)       Date:  2022-02-18       Impact factor: 1.817

6.  Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders.

Authors:  James E Heubi; Kevin E Bove; Kenneth D R Setchell
Journal:  J Pediatr Gastroenterol Nutr       Date:  2017-09       Impact factor: 2.839

7.  Cholic acid for primary bile acid synthesis defects: a life-saving therapy allowing a favorable outcome in adulthood.

Authors:  Emmanuel Gonzales; Lorenza Matarazzo; Stéphanie Franchi-Abella; Alain Dabadie; Joseph Cohen; Dalila Habes; Sophie Hillaire; Catherine Guettier; Anne-Marie Taburet; Anne Myara; Emmanuel Jacquemin
Journal:  Orphanet J Rare Dis       Date:  2018-10-29       Impact factor: 4.123

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.